Avita Medical Inc. held its 2025 Annual Meeting of Stockholders via live webcast on June 4, 2025. During the meeting, all seven directors named in the Proxy Statement were elected to the Board of Directors. Stockholders approved the Amended and Restated 2020 Omnibus Incentive Plan, which increased the number of shares available for issuance. Additionally, grants of options and restricted stock units to non-executive directors and the Chief Executive Officer were approved.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.